NCT03477266

Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery

Effectiveness of Mouth Dissolving Mosapride Tablets on Enhancing Gut Recovery After Cesarean Section: Randomized Double-blind, Placebo-controlled Clinical Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 400 (actual)
• Sponsor: Benha University · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functions

Detailed description

Uncomplicated post cesarean women one day before and immediately after elective cesarean receive 2 mouthly dissolving mosapride tablets every 8 hours maximum for 5 days and clinical care giver follow the woman's gastrointestinal functions, including intraoperative and postoperative nausea vomiting, passing flatus, hearing intestinal sounds, passing stools, occurring of paralytic ileus, length of the hospital stay

Conditions

• Prevention of Postoperative Ileus

Interventions

Type	Name	Description
DRUG	Mosapride	Intake mouthly dissolving mosapride tablets in immediate post cesarean section
DRUG	Placebo Oral Tablet	Dummy identical tablets to mouthly dissolving mosapride tablets

Timeline

• Start date: 2018-04-01
• Primary completion: 2018-06-01
• Completion: 2018-08-01
• First posted: 2018-03-26
• Last updated: 2018-08-14

Locations

1 site across 1 country: Egypt